UTAH MEDICAL PRODUCTS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price of $74.56 per share as of 2023-12-31, per its 10-K filed 2024-03-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 · last filed 2024-03-26
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $74.56.
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $73.66.
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $69.24.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $67.23.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2023-12-31 | $74.56 10-K · filed 2024-03-26 |
| 2022-12-31 | $73.66 10-K/A · filed 2023-03-28 |
| 2021-12-31 | $69.24 10-K · filed 2022-03-25 |
| 2020-12-31 | $67.23 10-K · filed 2021-03-26 |
| 2019-12-31 | $58.50 10-K · filed 2020-03-16 |
| 2018-12-31 | $56.78 10-K · filed 2019-03-14 |
| 2017-12-31 | $45.50 10-K · filed 2018-03-06 |
| 2016-12-31 | $46.62 10-K · filed 2017-03-08 |
| 2015-12-31 | $38.69 10-K · filed 2016-03-10 |
| 2014-12-31 | $36.70 10-K · filed 2015-03-12 |
| 2013-12-31 | $27.39 10-K · filed 2014-03-12 |
| 2012-12-31 | $26.68 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |